RXRX icon

Recursion Pharmaceuticals

333 hedge funds and large institutions have $1.61B invested in Recursion Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 137 increasing their positions, 67 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

2.41% less ownership

Funds ownership: 79.42%77.01% (-2.4%)

10% less funds holding in top 10

Funds holding in top 10: 109 (-1)

22% less capital invested

Capital invested by funds: $2.06B → $1.61B (-$451M)

Holders
333
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
9
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$28.3M
Puts
$21.7M
Net Calls
Net Calls Change

Top Buyers

1 +$22M
2 +$13.6M
3 +$13.1M
4
Morgan Stanley
Morgan Stanley
New York
+$11.4M
5
KA
Kinnevik AB
Sweden
+$8.09M